IC
ANRO icon

IEQ Capital’s Alto Neuroscience ANRO Stock Holding History

IEQ Capital’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$533K Sell
23,727
-51,567
-68% -$956K ﹤0.01% 1277
2025
Q4 		$1.34M Buy
75,294
+12,315
+20% +$155K ﹤0.01% 926
2025
Q3 		$253K Sell
62,979
-2,210
-3% -$7.33K ﹤0.01% 1589
2025
Q2 		$143K Hold
65,189
– – ﹤0.01% 1672
2025
Q1 		$141K Hold
65,189
– – ﹤0.01% 1437
2024
Q4 		$276K Hold
65,189
– – ﹤0.01% 1059
2024
Q3 		$746K Buy
+65,189
New +$798K 0.01% 629

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

IEQ Capital's ANRO Position: Q1 2026 in Review

IEQ Capital reduced its Alto Neuroscience (ANRO) stake by 68% in Q1 2026, selling an estimated $956K and leaving 23,727 shares worth $533K. The position accounts for ﹤0.01% of the portfolio, ranked #1277.

IEQ Capital first reported a position in ANRO in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.34M in Q4 2025. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • IEQ Capital held 23,727 shares of Alto Neuroscience worth $533K as of Q1 2026.
  • IEQ Capital sold 51,567 Alto Neuroscience shares in Q1 2026, an estimated $956K.
  • Alto Neuroscience made up ﹤0.01% of IEQ Capital's portfolio in Q1 2026, its #1277 holding.
  • IEQ Capital first reported a position in Alto Neuroscience in Q3 2024 and has held it in 7 quarters since.
  • IEQ Capital's Alto Neuroscience position peaked at $1.34M in Q4 2025.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.